ABL Bio Inc. (298380.KQ) KOE
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
ABL Bio Inc.
Address
16 Daewangpangyo-Ro 712 Beon-Gil
Seongnam, 13488
Korea (the Republic of)
Phone
82 31 8018 9800
Website
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
102
First IPO Date
December 19, 2018
Key Executives
| Name | Title | Pay | Year Born |
| Sang Hoon Lee | Founder, President & Chief Executive Officer | 889M | N/A |
| Jaecheon Lee | Executive Vice President, MD & Chief Financial Officer | 595M | N/A |
| Jung Dae Kim | Executive Vice President & Chief Operating Officer | 0 | N/A |
| Sung Ju Moon | Executive Vice President & Chief ADC Development Officer | 0 | N/A |
| Hakju Kwon | Senior Vice President, Head of Neuroscience & NCD | 0 | N/A |
| You Weon-Kyoo | Executive Vice President, Chief Scientific Officer & Head of R&D | 0 | N/A |
AD
Description
ABL Bio Inc. is a biotechnology research company based in Seongnam, South Korea. The firm is dedicated to advancing therapeutic medications, primarily concentrating its efforts on treatments for immuno-oncology and neurodegenerative conditions. Its current lineup of investigational drugs features ABL001, various cancer immunotherapies, ADCs, and ABL301.
AD
